{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:46:31Z","timestamp":1761864391719},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11934-022-01083-z","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T01:02:40Z","timestamp":1644800560000},"page":"11-18","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Review of the Economics of Surgical Treatment Options for Benign Prostatic Hyperplasia"],"prefix":"10.1007","volume":"23","author":[{"given":"Oluwatobi","family":"Aladesuru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananth","family":"Punyala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelina","family":"Stoddard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naeem","family":"Bhojani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Zorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Elterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal","family":"Chughtai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"1083_CR1","unstructured":"Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol [Internet]. 2015 [cited 2020 Dec 29];22:1\u20136. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26497338\/."},{"key":"1083_CR2","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Gill BC, Ulchaker JC. Costs of managing benign prostatic hyperplasia in the office and operating room [Internet]. Vol. 19, Cur Urol Rep. Current Medicine Group LLC 1; 2018 [cited 2021 May 7]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30022307\/. Patient-reported outcomes comparison of PUL and TURP.","DOI":"10.1007\/s11934-018-0822-z"},{"key":"1083_CR3","doi-asserted-by":"crossref","unstructured":"Chirikos TN, Sanford E. Cost consequences of surveillance, medical management or surgery for benign prostatic hyperplasia. J Urol [Internet]. 1996 Apr;155(4):1311\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8632563.","DOI":"10.1016\/S0022-5347(01)66254-2"},{"key":"1083_CR4","doi-asserted-by":"crossref","unstructured":"Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC, Mebust WK, Holtgrewe HL, et al. Transurethral prostatectomy: immediate and postoperative complications. Cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol [Internet]. 2002 [cited 2021 May 7];167(1):5\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11743263\/.","DOI":"10.1016\/S0022-5347(05)65370-0"},{"key":"1083_CR5","doi-asserted-by":"crossref","unstructured":"Goh AC, Gonzalez RR. Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis. J Urol [Internet]. 2010 Apr;183(4):1469\u201373. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20172555.","DOI":"10.1016\/j.juro.2009.12.020"},{"key":"1083_CR6","doi-asserted-by":"crossref","unstructured":"Bagla S, Smirniotopoulos J, Orlando J, Piechowiak R. Cost analysis of prostate artery embolization (PAE) and transurethral resection of the prostate (TURP) in the treatment of benign prostatic hyperplasia. Cardiovasc Intervent Radiol [Internet]. 2017 Nov 30;40(11):1694\u20137. Available from: http:\/\/link.springer.com\/10.1007\/s00270-017-1700-7.","DOI":"10.1007\/s00270-017-1700-7"},{"key":"1083_CR7","unstructured":"Kabalin JN, Butler ED. Costs of minimally invasive laser surgery compared with transurethral electrocautery resection of the prostate. West J Med [Internet]. 1995 May;162(5):426\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7785256."},{"key":"1083_CR8","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 DeWitt-Foy ME, Gill BC, Ulchaker JC. Cost comparison of benign prostatic hyperplasia treatment options. Curr Urol Rep [Internet]. 2019 Aug 19;20(8):45. Available from: http:\/\/link.springer.com\/10.1007\/s11934-019-0907-3. Costs associated with transabdominal procedures.","DOI":"10.1007\/s11934-019-0907-3"},{"key":"1083_CR9","doi-asserted-by":"crossref","unstructured":"Crivellaro S, Sofer L, Halgrimson WR, Dobbs RW, Serafini P. Optimized clinical decision-making: a configurable markov model for benign prostatic hyperplasia treatment. Urology [Internet]. 2019 Oct 1 [cited 2020 Dec 28];132:183\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31254572\/.","DOI":"10.1016\/j.urology.2019.06.022"},{"key":"1083_CR10","doi-asserted-by":"crossref","unstructured":"Moore HG, Thomas D, Chughtai B. Holmium Enucleation of the Prostate. In: A Comprehensive Guide to the Prostate. Elsevier; 2018. p. 73\u20139.","DOI":"10.1016\/B978-0-12-811464-3.00011-8"},{"issue":"4","key":"1083_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.urols.2016.07.003","volume":"27","author":"CH Chen","year":"2016","unstructured":"Chen CH, Chiang PH. GreenLight 180-W XPS laser versus 120-W HPS laser for the treatment of benign prostate hyperplasia by a single experienced urologist. Urol Sci. 2016;27(4):234\u20137.","journal-title":"Urol Sci"},{"key":"1083_CR12","doi-asserted-by":"crossref","unstructured":"Jepsen J V., Bruskewitz RC. Economics of transurethral thermotherapy of the prostate. World J Urol [Internet]. 1998 [cited 2021 May 7];16(2):138\u201341. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12073228\/.","DOI":"10.1007\/s003450050040"},{"key":"1083_CR13","doi-asserted-by":"crossref","unstructured":"Vale JA, Bdesha AS, Witherow RO. An analysis of the costs of alternative treatments for benign prostatic hypertrophy. J R Soc Med [Internet]. 1995 Nov;88(11):644P-648P. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8544151.","DOI":"10.1177\/014107689508801111"},{"key":"1083_CR14","doi-asserted-by":"crossref","unstructured":"DiSantostefano RL, Biddle AK, Lavelle JP. The long-term cost effectiveness of treatments for benign prostatic hyperplasia. Pharmacoeconomics [Internet]. 2006;24(2):171\u201391. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16460137.","DOI":"10.2165\/00019053-200624020-00006"},{"key":"1083_CR15","doi-asserted-by":"crossref","unstructured":"Knight GM, Talwar A, Salem R, Mouli S. Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia [Internet]. Vol. 44, Cardiovasc Interv Radiol. Springer; 2021 [cited 2021 Jun 9]. p. 183\u201393. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33078236\/.","DOI":"10.1007\/s00270-020-02657-5"},{"issue":"4","key":"1083_CR16","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/01.ju.0000152318.79184.6f","volume":"173","author":"CS Saigal","year":"2005","unstructured":"Saigal CS, Joyce G. Economic costs of benign prostatic hyperplasia in the private sector. J Urol. 2005;173(4):1309\u201313.","journal-title":"J Urol"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-022-01083-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-022-01083-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-022-01083-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T19:53:38Z","timestamp":1674762818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-022-01083-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1083"],"URL":"https:\/\/doi.org\/10.1007\/s11934-022-01083-z","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"17 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Bilal Chughtai is a consultant at Boston Scientific, Olympus, MedeonBio, Urovant, Ferring, and MediTate. Dean Elterman is a consultant and investigator for Boston Scientific, Procept Biorobotics, MedionBio, and Urotronic. Kevin Zorn is a consultant at Boston Scientific and Procept Biorobotics. Naeem Bhojani is a consultant and investigator for Boston Scientific, Olympus, and PROCEPT BioRobotics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}